Global Hospital Acquired Infection Control Market Size study & Forecast, by Product & Service by Infection Type and End User and Regional Forecasts 2025-2035

Description

Valued at approximately USD 21.1 billion in 2024, the global hospital acquired infection (HAI) control market is anticipated to expand at a notable CAGR of 6.80% over the forecast period of 2025-2035. The market is witnessing an unprecedented wave of transformation as healthcare systems across the globe intensify their efforts to prevent, monitor, and eradicate HAIs, which remain one of the leading causes of morbidity and extended hospital stays. The rising prevalence of multi-drug-resistant pathogens, coupled with an aging population and a growing number of immunocompromised patients, has intensified the urgency for advanced infection control protocols. As hospitals navigate increasingly complex care environments, they are leaning heavily on robust sterilization technologies, sophisticated disinfection solutions, and comprehensive service models that ensure adherence to rigorous hygiene standards while optimizing operational efficiency.

In recent years, technological advancements and process innovations have accelerated the development of more effective sterilization and disinfection systems, which have become indispensable for safeguarding both patient and staff health. According to the World Health Organization, hundreds of millions of patients are affected by HAIs annually, with surgical site infections, bloodstream infections, and ventilator-associated pneumonia ranking among the most frequent. Heightened awareness among healthcare administrators about the economic burden of HAIs-ranging from increased treatment costs to reduced patient throughput-has galvanized investments in modern equipment and preventive strategies. The demand for contract sterilization services has surged, enabling facilities to outsource specialized processes and ensure compliance without overburdening in-house resources. However, the significant upfront costs of advanced equipment and the persistent shortage of skilled infection control professionals in certain regions could temper the pace of adoption.

Geographically, North America held the dominant market position in 2024, propelled by stringent regulatory frameworks, high healthcare expenditure, and rapid uptake of advanced sterilization and disinfection solutions across hospitals and surgical centers. The U.S. has been at the forefront of implementing hospital-wide infection prevention programs, supported by robust reimbursement policies and accreditation requirements. Europe remains a mature but competitive market, driven by its strong public healthcare systems and adherence to strict hygiene regulations, with Germany, the UK, and France leading the charge in equipment modernization. Meanwhile, Asia Pacific is emerging as the fastest-growing region, with surging healthcare infrastructure investments in China, India, and Southeast Asia fueling demand for infection control solutions. The region's expanding hospital capacity, coupled with increasing public-private partnerships in the healthcare sector, is expected to create a fertile environment for sustained market growth through 2035.

Major market player included in this report are:

Steris Corporation
Getinge AB
3M Company
Ecolab Inc.
Sotera Health Company
Advanced Sterilization Products (ASP)
Matachana Group
Belimed AG
MMM Group
Olympus Corporation
Kimberly-Clark Corporation
Cantel Medical (part of Steris)
Fortive Corporation (Fluke Biomedical)
Reckitt Benckiser Group plc
Johnson & Johnson Services, Inc.

Global Hospital Acquired Infection Control Market Report Scope:

Historical Data - 2023, 2024
Base Year for Estimation - 2024
Forecast period - 2025-2035
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

By Product & Service:

Sterilization
Heat Sterilization Equipment
Low Temperature Sterilization Equipment
Radiation Sterilization Equipment
Other Sterilization Equipment
Contract Sterilization Services
Sterilization Consumables & Accessories
Cleaning & Disinfection Products

By Infection Type:

Hospital-Acquired Pneumonia
Bloodstream Infections
Surgical Site Infections
Gastrointestinal Infections
Urinary Tract Infections (UTI)
Others

By End User:

Hospitals & Clinics
Ambulatory Surgical Centers
Others

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
South Africa
Rest of Middle East & Africa

Key Takeaways:

Market Estimates & Forecast for 10 years from 2025 to 2035.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Hospital Acquired Infection Control Market Report Scope & Methodology

1.1. Research Objective
1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study (Historical Data - 2023, 2024; Base Year for Estimation - 2024; Forecast period - 2025-2035)

Chapter 2. Executive Summary

2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Key Findings

Chapter 3. Global Hospital Acquired Infection Control Market Forces Analysis

3.1. Market Forces Shaping The Global Hospital Acquired Infection Control Market (2024-2035)
3.2. Drivers
- 3.2.1. Rising incidence of multi-drug resistant organisms and increased infection rates in acute care settings
- 3.2.2. Growing number of surgical procedures, aging populations and expansion of critical care services
- 3.2.3. Stringent regulatory norms, accreditation requirements and reimbursement incentives for infection prevention
- 3.2.4. Increased adoption of advanced sterilization and disinfection technologies (e.g., H2O2 vapor, UV-C, automated washers)
3.3. Restraints
- 3.3.1. High capital expenditure and total cost of ownership for advanced sterilization equipment
- 3.3.2. Shortage of trained infection prevention professionals and operational skilled workforce in emerging markets
- 3.3.3. Supply chain disruptions for critical consumables and single-use items
3.4. Opportunities
- 3.4.1. Rising healthcare investments and hospital expansion in Asia Pacific and Latin America
- 3.4.2. Outsourcing/contract sterilization services and recurring consumables revenue models
- 3.4.3. Integration of IoT and automation for instrument tracking and compliance monitoring
- 3.4.4. Development of rapid, low-temperature sterilization platforms for delicate/complex devices

Chapter 4. Global Hospital Acquired Infection Control Industry Analysis

4.1. Porter's 5 Forces Model
- 4.1.1. Bargaining Power of Buyer
- 4.1.2. Bargaining Power of Supplier
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Hospital Acquired Infection Control Market Size & Forecasts by Product & Service 2025-2035

5.1. Market Overview
5.2. Global Hospital Acquired Infection Control Market Performance - Potential Analysis (2025)
5.3. Sterilization (Heat Sterilization Equipment, Low Temperature Sterilization Equipment, Radiation Sterilization Equipment, Other Sterilization Equipment)
- 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.3.2. Market size analysis, by region, 2025-2035
5.4. Contract Sterilization Services
- 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.4.2. Market size analysis, by region, 2025-2035
5.5. Sterilization Consumables & Accessories
- 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.5.2. Market size analysis, by region, 2025-2035
5.6. Cleaning & Disinfection Products
- 5.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.6.2. Market size analysis, by region, 2025-2035

Chapter 6. Global Hospital Acquired Infection Control Market Size & Forecasts by Infection Type 2025-2035

6.1. Market Overview
6.2. Global Hospital Acquired Infection Control Market Performance - Potential Analysis (2025)
6.3. Hospital-Acquired Pneumonia
- 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.3.2. Market size analysis, by region, 2025-2035
6.4. Bloodstream Infections
- 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.4.2. Market size analysis, by region, 2025-2035
6.5. Surgical Site Infections
- 6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.5.2. Market size analysis, by region, 2025-2035
6.6. Gastrointestinal Infections
- 6.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.6.2. Market size analysis, by region, 2025-2035
6.7. Urinary Tract Infections (UTI)
- 6.7.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.7.2. Market size analysis, by region, 2025-2035
6.8. Others
- 6.8.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.8.2. Market size analysis, by region, 2025-2035

Chapter 7. Global Hospital Acquired Infection Control Market Size & Forecasts by Region 2025-2035

7.1. Hospital Acquired Infection Control Market, Regional Market Snapshot
7.2. Top Leading & Emerging Countries
7.3. North America Hospital Acquired Infection Control Market
- 7.3.1. U.S. Hospital Acquired Infection Control Market
  - 7.3.1.1. Product & Service (Sterilization, Contract Services, Consumables, Cleaning & Disinfection) breakdown size & forecasts, 2025-2035
  - 7.3.1.2. Infection Type (HAP, BSI, SSI, GI, UTI, Others) breakdown size & forecasts, 2025-2035
- 7.3.2. Canada Hospital Acquired Infection Control Market
  - 7.3.2.1. Product & Service breakdown size & forecasts, 2025-2035
  - 7.3.2.2. Infection Type breakdown size & forecasts, 2025-2035
7.4. Europe Hospital Acquired Infection Control Market
- 7.4.1. UK Hospital Acquired Infection Control Market
  - 7.4.1.1. Product & Service breakdown size & forecasts, 2025-2035
  - 7.4.1.2. Infection Type breakdown size & forecasts, 2025-2035
- 7.4.2. Germany Hospital Acquired Infection Control Market
  - 7.4.2.1. Product & Service breakdown size & forecasts, 2025-2035
  - 7.4.2.2. Infection Type breakdown size & forecasts, 2025-2035
- 7.4.3. France Hospital Acquired Infection Control Market
  - 7.4.3.1. Product & Service breakdown size & forecasts, 2025-2035
  - 7.4.3.2. Infection Type breakdown size & forecasts, 2025-2035
- 7.4.4. Spain Hospital Acquired Infection Control Market
  - 7.4.4.1. Product & Service breakdown size & forecasts, 2025-2035
  - 7.4.4.2. Infection Type breakdown size & forecasts, 2025-2035
- 7.4.5. Italy Hospital Acquired Infection Control Market
  - 7.4.5.1. Product & Service breakdown size & forecasts, 2025-2035
  - 7.4.5.2. Infection Type breakdown size & forecasts, 2025-2035
- 7.4.6. Rest of Europe Hospital Acquired Infection Control Market
  - 7.4.6.1. Product & Service breakdown size & forecasts, 2025-2035
  - 7.4.6.2. Infection Type breakdown size & forecasts, 2025-2035
7.5. Asia Pacific Hospital Acquired Infection Control Market
- 7.5.1. China Hospital Acquired Infection Control Market
  - 7.5.1.1. Product & Service breakdown size & forecasts, 2025-2035
  - 7.5.1.2. Infection Type breakdown size & forecasts, 2025-2035
- 7.5.2. India Hospital Acquired Infection Control Market
  - 7.5.2.1. Product & Service breakdown size & forecasts, 2025-2035
  - 7.5.2.2. Infection Type breakdown size & forecasts, 2025-2035
- 7.5.3. Japan Hospital Acquired Infection Control Market
  - 7.5.3.1. Product & Service breakdown size & forecasts, 2025-2035
  - 7.5.3.2. Infection Type breakdown size & forecasts, 2025-2035
- 7.5.4. Australia Hospital Acquired Infection Control Market
  - 7.5.4.1. Product & Service breakdown size & forecasts, 2025-2035
  - 7.5.4.2. Infection Type breakdown size & forecasts, 2025-2035
- 7.5.5. South Korea Hospital Acquired Infection Control Market
  - 7.5.5.1. Product & Service breakdown size & forecasts, 2025-2035
  - 7.5.5.2. Infection Type breakdown size & forecasts, 2025-2035
- 7.5.6. Rest of APAC Hospital Acquired Infection Control Market
  - 7.5.6.1. Product & Service breakdown size & forecasts, 2025-2035
  - 7.5.6.2. Infection Type breakdown size & forecasts, 2025-2035
7.6. Latin America Hospital Acquired Infection Control Market
- 7.6.1. Brazil Hospital Acquired Infection Control Market
  - 7.6.1.1. Product & Service breakdown size & forecasts, 2025-2035
  - 7.6.1.2. Infection Type breakdown size & forecasts, 2025-2035
- 7.6.2. Mexico Hospital Acquired Infection Control Market
  - 7.6.2.1. Product & Service breakdown size & forecasts, 2025-2035
  - 7.6.2.2. Infection Type breakdown size & forecasts, 2025-2035
7.7. Middle East and Africa Hospital Acquired Infection Control Market
- 7.7.1. UAE Hospital Acquired Infection Control Market
  - 7.7.1.1. Product & Service breakdown size & forecasts, 2025-2035
  - 7.7.1.2. Infection Type breakdown size & forecasts, 2025-2035
- 7.7.2. Saudi Arabia (KSA) Hospital Acquired Infection Control Market
  - 7.7.2.1. Product & Service breakdown size & forecasts, 2025-2035
  - 7.7.2.2. Infection Type breakdown size & forecasts, 2025-2035
- 7.7.3. South Africa Hospital Acquired Infection Control Market
  - 7.7.3.1. Product & Service breakdown size & forecasts, 2025-2035
  - 7.7.3.2. Infection Type breakdown size & forecasts, 2025-2035

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies
8.2. Steris Corporation
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Financial Performance (Subject to Data Availability)
- 8.2.5. Product/Services Port
- 8.2.6. Recent Development
- 8.2.7. Market Strategies
- 8.2.8. SWOT Analysis
8.3. Getinge AB
8.4. 3M Company
8.5. Ecolab Inc.
8.6. Sotera Health Company
8.7. Advanced Sterilization Products (ASP)
8.8. Matachana Group
8.9. Belimed AG
8.10. MMM Group
8.11. Olympus Corporation
8.12. Kimberly-Clark Corporation
8.13. Cantel Medical (part of Steris)
8.14. Fortive Corporation (Fluke Biomedical)
8.15. Reckitt Benckiser Group plc
8.16. Johnson & Johnson Services, Inc.